Earnings Watch: Pfizer and Merck’s third-quarter numbers bolster hopes for drug company earnings

This post was originally published on this site

Pfizer Inc. and Merck & Co. cheered investors with better-than-expected earnings on Tuesday, bolstering expectations for the drug sector and sending both Dow Jones Industrial Average components higher in early trade.

Add Comment